|
|||||||
| |||||||
| |||||||
1 | AN ACT concerning criminal law.
| ||||||
2 | Be it enacted by the People of the State of Illinois,
| ||||||
3 | represented in the General Assembly:
| ||||||
4 | Section 5. The Illinois Controlled Substances Act is | ||||||
5 | amended by changing Sections 204, 401, and 402 as follows:
| ||||||
6 | (720 ILCS 570/204) (from Ch. 56 1/2, par. 1204)
| ||||||
7 | Sec. 204. (a) The controlled substances listed in this | ||||||
8 | Section are
included in Schedule I.
| ||||||
9 | (b) Unless specifically excepted or unless listed in | ||||||
10 | another
schedule, any of the following opiates, including their | ||||||
11 | isomers,
esters, ethers, salts, and salts of isomers, esters, | ||||||
12 | and ethers,
whenever the existence of such isomers, esters, | ||||||
13 | ethers and salts is
possible within the specific chemical | ||||||
14 | designation:
| ||||||
15 | (1) Acetylmethadol;
| ||||||
16 | (1.1) Acetyl-alpha-methylfentanyl
| ||||||
17 | (N-[1-(1-methyl-2-phenethyl)-
| ||||||
18 | 4-piperidinyl]-N-phenylacetamide);
| ||||||
19 | (2) Allylprodine;
| ||||||
20 | (3) Alphacetylmethadol, except
| ||||||
21 | levo-alphacetylmethadol (also known as levo-alpha-
| ||||||
22 | acetylmethadol, levomethadyl acetate, or LAAM);
| ||||||
23 | (4) Alphameprodine;
|
| |||||||
| |||||||
1 | (5) Alphamethadol;
| ||||||
2 | (6) Alpha-methylfentanyl
| ||||||
3 | (N-(1-alpha-methyl-beta-phenyl) ethyl-4-piperidyl)
| ||||||
4 | propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-
| ||||||
5 | propanilido) piperidine;
| ||||||
6 | (6.1) Alpha-methylthiofentanyl
| ||||||
7 | (N-[1-methyl-2-(2-thienyl)ethyl-
| ||||||
8 | 4-piperidinyl]-N-phenylpropanamide);
| ||||||
9 | (7) 1-methyl-4-phenyl-4-propionoxypiperidine (MPPP);
| ||||||
10 | (7.1) PEPAP
| ||||||
11 | (1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine);
| ||||||
12 | (8) Benzethidine;
| ||||||
13 | (9) Betacetylmethadol;
| ||||||
14 | (9.1) Beta-hydroxyfentanyl
| ||||||
15 | (N-[1-(2-hydroxy-2-phenethyl)-
| ||||||
16 | 4-piperidinyl]-N-phenylpropanamide);
| ||||||
17 | (10) Betameprodine;
| ||||||
18 | (11) Betamethadol;
| ||||||
19 | (12) Betaprodine;
| ||||||
20 | (13) Clonitazene;
| ||||||
21 | (14) Dextromoramide;
| ||||||
22 | (15) Diampromide;
| ||||||
23 | (16) Diethylthiambutene;
| ||||||
24 | (17) Difenoxin;
| ||||||
25 | (18) Dimenoxadol;
| ||||||
26 | (19) Dimepheptanol;
|
| |||||||
| |||||||
1 | (20) Dimethylthiambutene;
| ||||||
2 | (21) Dioxaphetylbutyrate;
| ||||||
3 | (22) Dipipanone;
| ||||||
4 | (23) Ethylmethylthiambutene;
| ||||||
5 | (24) Etonitazene;
| ||||||
6 | (25) Etoxeridine;
| ||||||
7 | (26) Furethidine;
| ||||||
8 | (27) Hydroxpethidine;
| ||||||
9 | (28) Ketobemidone;
| ||||||
10 | (29) Levomoramide;
| ||||||
11 | (30) Levophenacylmorphan;
| ||||||
12 | (31) 3-Methylfentanyl
| ||||||
13 | (N-[3-methyl-1-(2-phenylethyl)-
| ||||||
14 | 4-piperidyl]-N-phenylpropanamide);
| ||||||
15 | (31.1) 3-Methylthiofentanyl
| ||||||
16 | (N-[(3-methyl-1-(2-thienyl)ethyl-
| ||||||
17 | 4-piperidinyl]-N-phenylpropanamide);
| ||||||
18 | (32) Morpheridine;
| ||||||
19 | (33) Noracymethadol;
| ||||||
20 | (34) Norlevorphanol;
| ||||||
21 | (35) Normethadone;
| ||||||
22 | (36) Norpipanone;
| ||||||
23 | (36.1) Para-fluorofentanyl
| ||||||
24 | (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-
| ||||||
25 | 4-piperidinyl]propanamide);
| ||||||
26 | (37) Phenadoxone;
|
| |||||||
| |||||||
1 | (38) Phenampromide;
| ||||||
2 | (39) Phenomorphan;
| ||||||
3 | (40) Phenoperidine;
| ||||||
4 | (41) Piritramide;
| ||||||
5 | (42) Proheptazine;
| ||||||
6 | (43) Properidine;
| ||||||
7 | (44) Propiram;
| ||||||
8 | (45) Racemoramide;
| ||||||
9 | (45.1) Thiofentanyl
| ||||||
10 | (N-phenyl-N-[1-(2-thienyl)ethyl-
| ||||||
11 | 4-piperidinyl]-propanamide);
| ||||||
12 | (46) Tilidine;
| ||||||
13 | (47) Trimeperidine;
| ||||||
14 | (48) Beta-hydroxy-3-methylfentanyl (other name:
| ||||||
15 | N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-
| ||||||
16 | N-phenylpropanamide).
| ||||||
17 | (c) Unless specifically excepted or unless listed in | ||||||
18 | another
schedule, any of the following opium derivatives, its | ||||||
19 | salts, isomers
and salts of isomers, whenever the existence of | ||||||
20 | such salts, isomers and
salts of isomers is possible within the | ||||||
21 | specific chemical designation:
| ||||||
22 | (1) Acetorphine;
| ||||||
23 | (2) Acetyldihydrocodeine;
| ||||||
24 | (3) Benzylmorphine;
| ||||||
25 | (4) Codeine methylbromide;
| ||||||
26 | (5) Codeine-N-Oxide;
|
| |||||||
| |||||||
1 | (6) Cyprenorphine;
| ||||||
2 | (7) Desomorphine;
| ||||||
3 | (8) Diacetyldihydromorphine (Dihydroheroin);
| ||||||
4 | (9) Dihydromorphine;
| ||||||
5 | (10) Drotebanol;
| ||||||
6 | (11) Etorphine (except hydrochloride salt);
| ||||||
7 | (12) Heroin;
| ||||||
8 | (13) Hydromorphinol;
| ||||||
9 | (14) Methyldesorphine;
| ||||||
10 | (15) Methyldihydromorphine;
| ||||||
11 | (16) Morphine methylbromide;
| ||||||
12 | (17) Morphine methylsulfonate;
| ||||||
13 | (18) Morphine-N-Oxide;
| ||||||
14 | (19) Myrophine;
| ||||||
15 | (20) Nicocodeine;
| ||||||
16 | (21) Nicomorphine;
| ||||||
17 | (22) Normorphine;
| ||||||
18 | (23) Pholcodine;
| ||||||
19 | (24) Thebacon.
| ||||||
20 | (d) Unless specifically excepted or unless listed in | ||||||
21 | another
schedule, any material, compound, mixture, or | ||||||
22 | preparation which contains
any quantity of the following | ||||||
23 | hallucinogenic substances, or which
contains any of its salts, | ||||||
24 | isomers and salts of isomers, whenever the
existence of such | ||||||
25 | salts, isomers, and salts of isomers is possible
within the | ||||||
26 | specific chemical designation (for the purposes of this
|
| |||||||
| |||||||
1 | paragraph only, the term "isomer" includes the optical, | ||||||
2 | position and
geometric isomers):
| ||||||
3 | (1) 3,4-methylenedioxyamphetamine
| ||||||
4 | (alpha-methyl,3,4-methylenedioxyphenethylamine,
| ||||||
5 | methylenedioxyamphetamine, MDA);
| ||||||
6 | (1.1) Alpha-ethyltryptamine
| ||||||
7 | (some trade or other names: etryptamine;
| ||||||
8 | MONASE; alpha-ethyl-1H-indole-3-ethanamine;
| ||||||
9 | 3-(2-aminobutyl)indole; a-ET; and AET);
| ||||||
10 | (2) 3,4-methylenedioxymethamphetamine (MDMA);
| ||||||
11 | (2.1) 3,4-methylenedioxy-N-ethylamphetamine
| ||||||
12 | (also known as: N-ethyl-alpha-methyl-
| ||||||
13 | 3,4(methylenedioxy) Phenethylamine, N-ethyl MDA, MDE,
| ||||||
14 | and MDEA);
| ||||||
15 | (2.2) N-Benzylpiperazine (BZP);
| ||||||
16 | (3) 3-methoxy-4,5-methylenedioxyamphetamine, (MMDA);
| ||||||
17 | (4) 3,4,5-trimethoxyamphetamine (TMA);
| ||||||
18 | (5) (Blank);
| ||||||
19 | (6) Diethyltryptamine (DET);
| ||||||
20 | (7) Dimethyltryptamine (DMT);
| ||||||
21 | (8) 4-methyl-2,5-dimethoxyamphetamine (DOM, STP);
| ||||||
22 | (9) Ibogaine (some trade and other names:
| ||||||
23 | 7-ethyl-6,6,beta,7,8,9,10,12,13-octahydro-2-methoxy-
| ||||||
24 | 6,9-methano-5H-pyrido [1',2':1,2] azepino [5,4-b]
| ||||||
25 | indole; Tabernanthe iboga);
| ||||||
26 | (10) Lysergic acid diethylamide;
|
| |||||||
| |||||||
1 | (10.5) Salvia divinorum (meaning all parts of the plant | ||||||
2 | presently classified
botanically as Salvia divinorum, | ||||||
3 | whether growing or not, the
seeds thereof, any extract from | ||||||
4 | any part of that plant, and every compound,
manufacture, | ||||||
5 | salts, isomers, and salts of
isomers whenever the existence | ||||||
6 | of such salts, isomers, and salts of
isomers is possible | ||||||
7 | within the specific chemical designation, derivative, | ||||||
8 | mixture, or preparation of that plant, its
seeds or | ||||||
9 | extracts);
| ||||||
10 | (11) 3,4,5-trimethoxyphenethylamine (Mescaline);
| ||||||
11 | (12) Peyote (meaning all parts of the plant presently | ||||||
12 | classified
botanically as Lophophora williamsii
Lemaire, | ||||||
13 | whether growing or not, the
seeds thereof, any extract from | ||||||
14 | any part of that plant, and every compound,
manufacture, | ||||||
15 | salts, derivative, mixture, or preparation of that plant, | ||||||
16 | its
seeds or extracts);
| ||||||
17 | (13) N-ethyl-3-piperidyl benzilate (JB 318);
| ||||||
18 | (14) N-methyl-3-piperidyl benzilate;
| ||||||
19 | (14.1) N-hydroxy-3,4-methylenedioxyamphetamine
| ||||||
20 | (also known as N-hydroxy-alpha-methyl-
| ||||||
21 | 3,4(methylenedioxy)phenethylamine and N-hydroxy MDA);
| ||||||
22 | (15) Parahexyl; some trade or other names:
| ||||||
23 | 3-hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-
| ||||||
24 | dibenzo (b,d) pyran; Synhexyl;
| ||||||
25 | (16) Psilocybin;
| ||||||
26 | (17) Psilocyn;
|
| |||||||
| |||||||
1 | (18) Alpha-methyltryptamine (AMT);
| ||||||
2 | (19) 2,5-dimethoxyamphetamine
| ||||||
3 | (2,5-dimethoxy-alpha-methylphenethylamine; 2,5-DMA);
| ||||||
4 | (20) 4-bromo-2,5-dimethoxyamphetamine
| ||||||
5 | (4-bromo-2,5-dimethoxy-alpha-methylphenethylamine;
| ||||||
6 | 4-bromo-2,5-DMA);
| ||||||
7 | (20.1) 4-Bromo-2,5 dimethoxyphenethylamine.
| ||||||
8 | Some trade or other names: 2-(4-bromo-
| ||||||
9 | 2,5-dimethoxyphenyl)-1-aminoethane;
| ||||||
10 | alpha-desmethyl DOB, 2CB, Nexus;
| ||||||
11 | (21) 4-methoxyamphetamine
| ||||||
12 | (4-methoxy-alpha-methylphenethylamine;
| ||||||
13 | paramethoxyamphetamine; PMA);
| ||||||
14 | (22) (Blank);
| ||||||
15 | (23) Ethylamine analog of phencyclidine.
| ||||||
16 | Some trade or other names:
| ||||||
17 | N-ethyl-1-phenylcyclohexylamine,
| ||||||
18 | (1-phenylcyclohexyl) ethylamine,
| ||||||
19 | N-(1-phenylcyclohexyl) ethylamine, cyclohexamine, PCE;
| ||||||
20 | (24) Pyrrolidine analog of phencyclidine. Some trade | ||||||
21 | or other names:
1-(1-phenylcyclohexyl) pyrrolidine, PCPy, | ||||||
22 | PHP;
| ||||||
23 | (25) 5-methoxy-3,4-methylenedioxy-amphetamine;
| ||||||
24 | (26) 2,5-dimethoxy-4-ethylamphetamine
| ||||||
25 | (another name: DOET);
| ||||||
26 | (27) 1-[1-(2-thienyl)cyclohexyl] pyrrolidine
|
| |||||||
| |||||||
1 | (another name: TCPy);
| ||||||
2 | (28) (Blank);
| ||||||
3 | (29) Thiophene analog of phencyclidine (some trade
| ||||||
4 | or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine;
| ||||||
5 | 2-thienyl analog of phencyclidine; TPCP; TCP);
| ||||||
6 | (30) Bufotenine (some trade or other names:
| ||||||
7 | 3-(Beta-Dimethylaminoethyl)-5-hydroxyindole;
| ||||||
8 | 3-(2-dimethylaminoethyl)-5-indolol;
| ||||||
9 | 5-hydroxy-N,N-dimethyltryptamine;
| ||||||
10 | N,N-dimethylserotonin; mappine).
| ||||||
11 | (e) Unless specifically excepted or unless listed in | ||||||
12 | another
schedule, any material, compound, mixture, or | ||||||
13 | preparation which contains
any quantity of the following | ||||||
14 | substances having a depressant effect on
the central nervous | ||||||
15 | system, including its salts, isomers, and salts of
isomers | ||||||
16 | whenever the existence of such salts, isomers, and salts of
| ||||||
17 | isomers is possible within the specific chemical designation:
| ||||||
18 | (1) mecloqualone;
| ||||||
19 | (2) methaqualone; and
| ||||||
20 | (3) gamma hydroxybutyric acid.
| ||||||
21 | (f) Unless specifically excepted or unless listed in | ||||||
22 | another schedule,
any material, compound, mixture, or | ||||||
23 | preparation which contains any quantity
of the following | ||||||
24 | substances having a stimulant effect on the central nervous
| ||||||
25 | system, including its salts, isomers, and salts of isomers:
| ||||||
26 | (1) Fenethylline;
|
| |||||||
| |||||||
1 | (2) N-ethylamphetamine;
| ||||||
2 | (3) Aminorex (some other names:
| ||||||
3 | 2-amino-5-phenyl-2-oxazoline; aminoxaphen;
| ||||||
4 | 4-5-dihydro-5-phenyl-2-oxazolamine) and its
| ||||||
5 | salts, optical isomers, and salts of optical isomers;
| ||||||
6 | (4) Methcathinone (some other names:
| ||||||
7 | 2-methylamino-1-phenylpropan-1-one;
| ||||||
8 | Ephedrone; 2-(methylamino)-propiophenone;
| ||||||
9 | alpha-(methylamino)propiophenone; N-methylcathinone;
| ||||||
10 | methycathinone; Monomethylpropion; UR 1431) and its
| ||||||
11 | salts, optical isomers, and salts of optical isomers;
| ||||||
12 | (5) Cathinone (some trade or other names:
| ||||||
13 | 2-aminopropiophenone; alpha-aminopropiophenone;
| ||||||
14 | 2-amino-1-phenyl-propanone; norephedrone);
| ||||||
15 | (6) N,N-dimethylamphetamine (also known as:
| ||||||
16 | N,N-alpha-trimethyl-benzeneethanamine;
| ||||||
17 | N,N-alpha-trimethylphenethylamine);
| ||||||
18 | (7) (+ or -) cis-4-methylaminorex ((+ or -) cis-
| ||||||
19 | 4,5-dihydro-4-methyl-4-5-phenyl-2-oxazolamine).
| ||||||
20 | (g) Temporary listing of substances subject to emergency | ||||||
21 | scheduling.
Any material, compound, mixture, or preparation | ||||||
22 | that contains any quantity
of the following substances:
| ||||||
23 | (1) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide
| ||||||
24 | (benzylfentanyl), its optical isomers, isomers, salts,
| ||||||
25 | and salts of isomers;
| ||||||
26 | (2) N-[1(2-thienyl)
|
| |||||||
| |||||||
1 | methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl),
| ||||||
2 | its optical isomers, salts, and salts of isomers.
| ||||||
3 | (Source: P.A. 95-239, eff. 1-1-08; 95-331, eff. 8-21-07.)
| ||||||
4 | (720 ILCS 570/401) (from Ch. 56 1/2, par. 1401)
| ||||||
5 | Sec. 401. Except as authorized by this Act, it is unlawful | ||||||
6 | for any
person knowingly to manufacture or deliver, or possess | ||||||
7 | with intent to
manufacture or deliver, a controlled substance | ||||||
8 | other than methamphetamine, a counterfeit substance, or a | ||||||
9 | controlled
substance analog. A violation of this Act with | ||||||
10 | respect to each of the controlled
substances listed herein | ||||||
11 | constitutes a single and separate violation of this
Act. For | ||||||
12 | purposes of this Section, "controlled substance analog" or | ||||||
13 | "analog"
means a substance
which is intended for human | ||||||
14 | consumption, other than a controlled substance,
that has a | ||||||
15 | chemical structure substantially similar to that of a | ||||||
16 | controlled
substance in Schedule I or II, or that was | ||||||
17 | specifically designed to produce
an effect substantially | ||||||
18 | similar to that of a controlled substance in Schedule
I or II. | ||||||
19 | Examples of chemical classes in which controlled substance | ||||||
20 | analogs
are found include, but are not limited to, the | ||||||
21 | following: phenethylamines,
N-substituted piperidines, | ||||||
22 | morphinans, ecgonines, quinazolinones, substituted
indoles, | ||||||
23 | and arylcycloalkylamines. For purposes of this Act, a | ||||||
24 | controlled
substance analog shall be treated in the same manner | ||||||
25 | as the controlled
substance to which it is substantially |
| |||||||
| |||||||
1 | similar.
| ||||||
2 | (a) Any person who violates this Section with respect to | ||||||
3 | the following
amounts of controlled or counterfeit substances | ||||||
4 | or controlled substance
analogs, notwithstanding any of the | ||||||
5 | provisions of subsections (c),
(d), (e), (f), (g) or (h) to the | ||||||
6 | contrary, is guilty of a Class X felony
and shall be sentenced | ||||||
7 | to a term of imprisonment as provided in this subsection
(a) | ||||||
8 | and fined as provided in subsection (b):
| ||||||
9 | (1) (A) not less than 6 years and not more than 30 | ||||||
10 | years with respect
to 15 grams or more but less than | ||||||
11 | 100 grams of a substance containing
heroin, or an | ||||||
12 | analog thereof;
| ||||||
13 | (B) not less than 9 years and not more than 40 | ||||||
14 | years with respect to 100
grams or more but less than | ||||||
15 | 400 grams of a substance containing heroin, or
an | ||||||
16 | analog thereof;
| ||||||
17 | (C) not less than 12 years and not more than 50 | ||||||
18 | years with respect to
400 grams or more but less than | ||||||
19 | 900 grams of a substance containing heroin,
or an | ||||||
20 | analog thereof;
| ||||||
21 | (D) not less than 15 years and not more than 60 | ||||||
22 | years with respect to
900 grams or more of any | ||||||
23 | substance containing heroin, or an analog thereof;
| ||||||
24 | (1.5) (A) not less than 6 years and not more than 30 | ||||||
25 | years with respect to 15 grams or more but less than | ||||||
26 | 100 grams of a substance containing fentanyl, or an |
| |||||||
| |||||||
1 | analog thereof;
| ||||||
2 | (B) not less than 9 years and not more than 40 | ||||||
3 | years with respect to 100 grams or more but less than | ||||||
4 | 400 grams of a substance containing fentanyl, or an | ||||||
5 | analog thereof; | ||||||
6 | (C) not less than 12 years and not more than 50 | ||||||
7 | years with respect to 400 grams or more but less than | ||||||
8 | 900 grams of a substance containing fentanyl, or an | ||||||
9 | analog thereof; | ||||||
10 | (D) not less than 15 years and not more than 60 | ||||||
11 | years with respect to 900 grams or more of a substance | ||||||
12 | containing fentanyl, or an analog thereof;
| ||||||
13 | (2) (A) not less than 6 years and not more than 30 | ||||||
14 | years with respect
to 15 grams or more but less than | ||||||
15 | 100 grams of a substance containing
cocaine, or an | ||||||
16 | analog thereof;
| ||||||
17 | (B) not less than 9 years and not more than 40 | ||||||
18 | years with respect to 100
grams or more but less than | ||||||
19 | 400 grams of a substance containing cocaine, or
an | ||||||
20 | analog thereof;
| ||||||
21 | (C) not less than 12 years and not more than 50 | ||||||
22 | years with respect to
400 grams or more but less than | ||||||
23 | 900 grams of a substance containing cocaine,
or an | ||||||
24 | analog thereof;
| ||||||
25 | (D) not less than 15 years and not more than 60 | ||||||
26 | years with respect to
900 grams or more of any |
| |||||||
| |||||||
1 | substance containing cocaine, or an analog thereof;
| ||||||
2 | (3) (A) not less than 6 years and not more than 30 | ||||||
3 | years with respect
to 15 grams or more but less than | ||||||
4 | 100 grams of a substance containing
morphine, or an | ||||||
5 | analog thereof;
| ||||||
6 | (B) not less than 9 years and not more than 40 | ||||||
7 | years with respect to
100 grams or more but less than | ||||||
8 | 400 grams of a substance containing morphine,
or an | ||||||
9 | analog thereof;
| ||||||
10 | (C) not less than 12 years and not more than 50 | ||||||
11 | years with respect to
400 grams or more but less than | ||||||
12 | 900 grams of a substance containing
morphine, or an | ||||||
13 | analog thereof;
| ||||||
14 | (D) not less than 15 years and not more than 60 | ||||||
15 | years with respect to
900 grams or more of a substance | ||||||
16 | containing morphine, or an analog thereof;
| ||||||
17 | (4) 200 grams or more of any substance containing | ||||||
18 | peyote, or an
analog thereof;
| ||||||
19 | (5) 200 grams or more of any substance containing a | ||||||
20 | derivative of
barbituric acid or any of the salts of a | ||||||
21 | derivative of barbituric acid, or
an analog thereof;
| ||||||
22 | (6) 200 grams or more of any substance containing | ||||||
23 | amphetamine
or any salt of an optical isomer of | ||||||
24 | amphetamine,
or an analog thereof;
| ||||||
25 | (6.5) (blank);
| ||||||
26 | (6.6) (blank);
|
| |||||||
| |||||||
1 | (7) (A) not less than 6 years and not more than 30 | ||||||
2 | years with respect
to: (i) 15 grams or more but less | ||||||
3 | than 100 grams of a substance containing
lysergic acid | ||||||
4 | diethylamide (LSD), or an analog thereof, or (ii) 15 or
| ||||||
5 | more objects or 15 or more segregated parts of an | ||||||
6 | object or objects but
less than 200 objects or 200 | ||||||
7 | segregated parts of an object or objects
containing in | ||||||
8 | them or having upon them any amounts of any substance
| ||||||
9 | containing lysergic acid diethylamide (LSD), or an | ||||||
10 | analog thereof;
| ||||||
11 | (B) not less than 9 years and not more than 40 | ||||||
12 | years with respect
to: (i) 100 grams or more but less | ||||||
13 | than 400 grams of a substance containing
lysergic acid | ||||||
14 | diethylamide (LSD), or an analog thereof, or (ii) 200 | ||||||
15 | or more
objects or 200 or more segregated parts of an | ||||||
16 | object or objects but less
than 600 objects or less | ||||||
17 | than 600 segregated parts of an object or objects
| ||||||
18 | containing in them or having upon them any amount of | ||||||
19 | any substance
containing lysergic acid diethylamide | ||||||
20 | (LSD), or an analog thereof;
| ||||||
21 | (C) not less than 12 years and not more than 50 | ||||||
22 | years with respect
to: (i) 400 grams or more but less | ||||||
23 | than 900 grams of a substance containing
lysergic acid | ||||||
24 | diethylamide (LSD), or an analog thereof, or (ii) 600 | ||||||
25 | or more
objects or 600 or more segregated parts of an | ||||||
26 | object or objects but less
than 1500 objects or 1500 |
| |||||||
| |||||||
1 | segregated parts of an object or objects
containing in | ||||||
2 | them or having upon them any amount of any substance
| ||||||
3 | containing lysergic acid diethylamide (LSD), or an | ||||||
4 | analog thereof;
| ||||||
5 | (D) not less than 15 years and not more than 60 | ||||||
6 | years with respect
to: (i) 900 grams or more of any | ||||||
7 | substance containing lysergic acid
diethylamide (LSD), | ||||||
8 | or an analog thereof, or (ii) 1500 or more objects or
| ||||||
9 | 1500 or more segregated parts of an object or objects | ||||||
10 | containing in them or
having upon them any amount of a | ||||||
11 | substance containing lysergic acid
diethylamide (LSD), | ||||||
12 | or an analog thereof;
| ||||||
13 | (7.5) (A) not less than 6 years and not more than 30 | ||||||
14 | years with respect
to:
(i) 15
grams or more but less | ||||||
15 | than 100 grams of a substance listed in paragraph (1),
| ||||||
16 | (2), (2.1), (2.2), (3), (14.1), (19), (20), (20.1), | ||||||
17 | (21), (25), or (26) of subsection
(d) of Section 204, | ||||||
18 | or an analog or derivative thereof, or (ii) 15 or more
| ||||||
19 | pills, tablets, caplets, capsules, or objects but less | ||||||
20 | than 200 pills, tablets,
caplets, capsules, or objects | ||||||
21 | containing in them or having upon them any
amounts of | ||||||
22 | any substance listed in paragraph (1), (2), (2.1), | ||||||
23 | (2.2), (3), (14.1),
(19), (20), (20.1), (21), (25), or | ||||||
24 | (26) of subsection (d) of Section 204, or
an analog or | ||||||
25 | derivative thereof;
| ||||||
26 | (B) not less than 9 years and not more than 40 |
| |||||||
| |||||||
1 | years with respect to:
(i) 100 grams or more but less | ||||||
2 | than 400 grams of a substance listed in
paragraph (1), | ||||||
3 | (2), (2.1), (2.2), (3), (14.1), (19), (20),
(20.1), | ||||||
4 | (21), (25), or (26) of subsection (d) of Section 204, | ||||||
5 | or an analog or
derivative thereof, or (ii) 200 or more | ||||||
6 | pills, tablets, caplets, capsules, or
objects but less | ||||||
7 | than 600 pills, tablets, caplets, capsules, or objects
| ||||||
8 | containing in them or having upon them any amount of | ||||||
9 | any substance listed in
paragraph (1), (2), (2.1), | ||||||
10 | (2.2), (3), (14.1), (19), (20), (20.1), (21), (25), or | ||||||
11 | (26)
of subsection (d) of Section 204, or an analog or | ||||||
12 | derivative thereof;
| ||||||
13 | (C) not less than 12 years and not more than 50 | ||||||
14 | years with respect to:
(i) 400 grams or more but less | ||||||
15 | than 900 grams of a substance listed in
paragraph (1), | ||||||
16 | (2), (2.1), (2.2), (3), (14.1), (19), (20), (20.1), | ||||||
17 | (21), (25), or (26)
of subsection (d) of Section 204, | ||||||
18 | or an analog or derivative thereof,
or (ii) 600 or more | ||||||
19 | pills, tablets, caplets, capsules, or objects but less | ||||||
20 | than
1,500 pills, tablets, caplets, capsules, or | ||||||
21 | objects
containing in them or having upon them any | ||||||
22 | amount of any substance listed in
paragraph (1), (2), | ||||||
23 | (2.1), (2.2), (3), (14.1), (19), (20), (20.1), (21), | ||||||
24 | (25), or (26)
of subsection (d) of Section 204, or an | ||||||
25 | analog or derivative thereof;
| ||||||
26 | (D) not less than 15 years and not more than 60 |
| |||||||
| |||||||
1 | years with respect to:
(i) 900 grams or more of any | ||||||
2 | substance listed in paragraph (1), (2), (2.1),
(2.2), | ||||||
3 | (3), (14.1), (19), (20), (20.1), (21), (25), or (26) of | ||||||
4 | subsection (d) of
Section 204, or an analog or | ||||||
5 | derivative thereof, or (ii) 1,500 or more pills,
| ||||||
6 | tablets, caplets, capsules, or objects containing in | ||||||
7 | them or having upon them
any amount
of a substance | ||||||
8 | listed in paragraph (1), (2), (2.1), (2.2), (3), | ||||||
9 | (14.1), (19),
(20), (20.1), (21), (25), or (26)
of | ||||||
10 | subsection (d) of Section 204, or an analog or | ||||||
11 | derivative thereof;
| ||||||
12 | (8) 30 grams or more of any substance containing | ||||||
13 | pentazocine or any of
the salts, isomers and salts of | ||||||
14 | isomers of pentazocine, or an analog thereof;
| ||||||
15 | (9) 30 grams or more of any substance containing | ||||||
16 | methaqualone or any of
the salts, isomers and salts of | ||||||
17 | isomers of methaqualone, or an analog thereof;
| ||||||
18 | (10) 30 grams or more of any substance containing | ||||||
19 | phencyclidine or any
of the salts, isomers and salts of | ||||||
20 | isomers of phencyclidine (PCP),
or an analog thereof;
| ||||||
21 | (10.5) 30 grams or more of any substance containing | ||||||
22 | ketamine
or any of the salts, isomers and salts of isomers | ||||||
23 | of ketamine,
or an analog thereof;
| ||||||
24 | (11) 200 grams or more of any substance containing any | ||||||
25 | other controlled
substance classified in Schedules I or II, | ||||||
26 | or an analog thereof, which is
not otherwise included in |
| |||||||
| |||||||
1 | this subsection.
| ||||||
2 | (b) Any person sentenced with respect to violations of | ||||||
3 | paragraph (1),
(2), (3), (7), or (7.5) of subsection (a) | ||||||
4 | involving
100 grams or
more of the
controlled substance named | ||||||
5 | therein, may in addition to the penalties
provided therein, be | ||||||
6 | fined an amount not more than $500,000 or the full
street value | ||||||
7 | of the controlled or counterfeit substance or controlled | ||||||
8 | substance
analog, whichever is greater. The term "street value" | ||||||
9 | shall have the
meaning ascribed in Section 110-5 of the Code of | ||||||
10 | Criminal Procedure of
1963. Any person sentenced with respect | ||||||
11 | to any other provision of
subsection (a), may in addition to | ||||||
12 | the penalties provided therein, be fined
an amount not to | ||||||
13 | exceed $500,000. | ||||||
14 | (b-1) Excluding violations of this Act when the controlled | ||||||
15 | substance is fentanyl, any person sentenced to a term of | ||||||
16 | imprisonment with respect to violations of Section 401, 401.1, | ||||||
17 | 405, 405.1, 405.2, or 407, when the substance containing the | ||||||
18 | controlled substance contains any amount of fentanyl, 3 years | ||||||
19 | shall be added to the term of imprisonment imposed by the | ||||||
20 | court, and the maximum sentence for the offense shall be | ||||||
21 | increased by 3 years.
| ||||||
22 | (c) Any person who violates this Section with regard to the
| ||||||
23 | following amounts of controlled or counterfeit substances
or | ||||||
24 | controlled substance analogs, notwithstanding any of the | ||||||
25 | provisions of
subsections (a), (b), (d), (e), (f), (g) or (h) | ||||||
26 | to the
contrary, is guilty of a Class 1 felony. The fine for |
| |||||||
| |||||||
1 | violation of this
subsection (c) shall not be more than | ||||||
2 | $250,000:
| ||||||
3 | (1) 1 gram or more but less than 15 grams of any
| ||||||
4 | substance containing heroin, or an analog thereof;
| ||||||
5 | (1.5) 1 gram or more but less than 15 grams of any | ||||||
6 | substance containing fentanyl, or an analog thereof;
| ||||||
7 | (2) 1 gram or more but less than 15
grams of any | ||||||
8 | substance containing cocaine, or an analog thereof;
| ||||||
9 | (3) 10 grams or more but less than 15 grams of any | ||||||
10 | substance
containing morphine, or an analog thereof;
| ||||||
11 | (4) 50 grams or more but less than 200 grams of any | ||||||
12 | substance
containing peyote, or an analog thereof;
| ||||||
13 | (5) 50 grams or more but less than 200 grams of any | ||||||
14 | substance
containing a derivative of barbituric acid or any | ||||||
15 | of the salts of a
derivative of barbituric acid, or an | ||||||
16 | analog thereof;
| ||||||
17 | (6) 50 grams or more but less than 200 grams of any | ||||||
18 | substance
containing amphetamine or any salt of an optical | ||||||
19 | isomer
of amphetamine, or an analog thereof;
| ||||||
20 | (6.5) (blank);
| ||||||
21 | (7) (i) 5 grams or more but less than 15 grams of any | ||||||
22 | substance
containing lysergic acid diethylamide (LSD), or | ||||||
23 | an analog thereof,
or (ii)
more than 10 objects or more | ||||||
24 | than 10 segregated parts of an object or objects
but less | ||||||
25 | than 15 objects or less than 15 segregated parts of an | ||||||
26 | object
containing in them or having upon them any amount of |
| |||||||
| |||||||
1 | any substance
containing lysergic acid diethylamide (LSD), | ||||||
2 | or an analog thereof;
| ||||||
3 | (7.5) (i) 5 grams or more but less than 15 grams of any | ||||||
4 | substance listed
in paragraph (1), (2), (2.1), (2.2), (3), | ||||||
5 | (14.1), (19), (20), (20.1), (21), (25), or
(26) of | ||||||
6 | subsection (d) of Section 204, or an analog or derivative | ||||||
7 | thereof, or
(ii) more than 10 pills, tablets, caplets, | ||||||
8 | capsules, or objects but less than
15 pills, tablets, | ||||||
9 | caplets, capsules, or objects containing in them or having
| ||||||
10 | upon them any amount of any substance listed in paragraph | ||||||
11 | (1), (2), (2.1),
(2.2), (3), (14.1), (19), (20), (20.1), | ||||||
12 | (21), (25), or (26) of subsection (d) of
Section 204, or an | ||||||
13 | analog or derivative thereof;
| ||||||
14 | (8) 10 grams or more but less than 30 grams of any | ||||||
15 | substance
containing pentazocine or any of the salts, | ||||||
16 | isomers and salts of isomers of
pentazocine, or an analog | ||||||
17 | thereof;
| ||||||
18 | (9) 10 grams or more but less than 30 grams of any | ||||||
19 | substance
containing methaqualone or any of the salts, | ||||||
20 | isomers and salts of isomers
of methaqualone, or an analog | ||||||
21 | thereof;
| ||||||
22 | (10) 10 grams or more but less than 30 grams of any | ||||||
23 | substance
containing phencyclidine or any of the salts, | ||||||
24 | isomers and salts of isomers
of phencyclidine (PCP), or an | ||||||
25 | analog thereof;
| ||||||
26 | (10.5) 10 grams or more but less than 30 grams of any |
| |||||||
| |||||||
1 | substance
containing ketamine or any of the salts, isomers | ||||||
2 | and salts of
isomers of ketamine, or an analog thereof;
| ||||||
3 | (11) 50 grams or more but less than 200 grams of any | ||||||
4 | substance
containing a substance classified in Schedules I | ||||||
5 | or II, or an analog
thereof, which is not otherwise | ||||||
6 | included in this subsection.
| ||||||
7 | (c-5) (Blank).
| ||||||
8 | (d) Any person who violates this Section with regard to any | ||||||
9 | other
amount of a controlled or counterfeit substance | ||||||
10 | classified in
Schedules I or II, or an analog thereof, which is | ||||||
11 | (i) a narcotic
drug, (ii) lysergic acid diethylamide (LSD) or | ||||||
12 | an analog thereof, or
(iii) any
substance containing | ||||||
13 | amphetamine or fentanyl or any salt or optical
isomer of | ||||||
14 | amphetamine or fentanyl, or an analog thereof, or (iv) any
| ||||||
15 | substance containing N-Benzylpiperazine (BZP) or any salt or | ||||||
16 | optical
isomer of N-Benzylpiperazine (BZP), or an analog | ||||||
17 | thereof, is guilty
of a Class 2 felony. The fine for violation | ||||||
18 | of this subsection (d) shall
not be more than $200,000.
| ||||||
19 | (d-5) (Blank).
| ||||||
20 | (e) Any person who violates this Section with regard to any | ||||||
21 | other
amount of a controlled substance other than | ||||||
22 | methamphetamine or counterfeit substance classified in
| ||||||
23 | Schedule I or II, or an analog thereof, which substance is not
| ||||||
24 | included under subsection (d) of this Section, is
guilty of a | ||||||
25 | Class 3 felony. The fine for violation of this subsection (e)
| ||||||
26 | shall not be more than $150,000.
|
| |||||||
| |||||||
1 | (f) Any person who violates this Section with regard to any | ||||||
2 | other
amount of a controlled or counterfeit substance | ||||||
3 | classified in
Schedule III is guilty of a Class 3 felony. The | ||||||
4 | fine for violation of
this subsection (f) shall not be more | ||||||
5 | than $125,000.
| ||||||
6 | (g) Any person who violates this Section with regard to any | ||||||
7 | other
amount of a controlled or counterfeit substance | ||||||
8 | classified
in Schedule IV is guilty of a Class 3 felony. The | ||||||
9 | fine for violation of
this subsection (g) shall not be more | ||||||
10 | than $100,000.
| ||||||
11 | (h) Any person who violates this Section with regard to any | ||||||
12 | other
amount of a controlled or counterfeit substance | ||||||
13 | classified in
Schedule V is guilty of a Class 3 felony. The | ||||||
14 | fine for violation of this
subsection (h) shall not be more | ||||||
15 | than $75,000.
| ||||||
16 | (i) This Section does not apply to the manufacture, | ||||||
17 | possession or
distribution of a substance in conformance with | ||||||
18 | the provisions of an approved
new drug application or an | ||||||
19 | exemption for investigational use within the
meaning of Section | ||||||
20 | 505 of the Federal Food, Drug and Cosmetic Act.
| ||||||
21 | (j) (Blank).
| ||||||
22 | (Source: P.A. 94-556, eff. 9-11-05; 95-259, eff. 8-17-07.)
| ||||||
23 | (720 ILCS 570/402) (from Ch. 56 1/2, par. 1402)
| ||||||
24 | Sec. 402. Except as otherwise authorized by this Act, it is | ||||||
25 | unlawful for
any person knowingly to possess a controlled or |
| |||||||
| |||||||
1 | counterfeit substance or controlled substance analog.
A | ||||||
2 | violation of this Act with respect to each of the controlled | ||||||
3 | substances
listed herein constitutes a single and separate | ||||||
4 | violation of this Act. For purposes of this Section, | ||||||
5 | "controlled substance analog" or "analog"
means a substance
| ||||||
6 | which is intended for human consumption, other than a | ||||||
7 | controlled substance,
that has a chemical structure | ||||||
8 | substantially similar to that of a controlled
substance in | ||||||
9 | Schedule I or II, or that was specifically designed to produce
| ||||||
10 | an effect substantially similar to that of a controlled | ||||||
11 | substance in Schedule
I or II. Examples of chemical classes in | ||||||
12 | which controlled substance analogs
are found include, but are | ||||||
13 | not limited to, the following: phenethylamines,
N-substituted | ||||||
14 | piperidines, morphinans, ecgonines, quinazolinones, | ||||||
15 | substituted
indoles, and arylcycloalkylamines. For purposes of | ||||||
16 | this Act, a controlled
substance analog shall be treated in the | ||||||
17 | same manner as the controlled
substance to which it is | ||||||
18 | substantially similar.
| ||||||
19 | (a) Any person who violates this Section with respect to | ||||||
20 | the following
controlled or counterfeit substances and | ||||||
21 | amounts, notwithstanding any of the
provisions of subsections | ||||||
22 | (c) and (d) to the
contrary, is guilty of a Class 1 felony and | ||||||
23 | shall, if sentenced to a term
of imprisonment, be sentenced as | ||||||
24 | provided in this subsection (a) and fined
as provided in | ||||||
25 | subsection (b):
| ||||||
26 | (1) (A) not less than 4 years and not more than 15 |
| |||||||
| |||||||
1 | years with respect
to 15 grams or more but less than | ||||||
2 | 100 grams of a substance containing heroin;
| ||||||
3 | (B) not less than 6 years and not more than 30 | ||||||
4 | years with respect to 100
grams or more but less than | ||||||
5 | 400 grams of a substance containing heroin;
| ||||||
6 | (C) not less than 8 years and not more than 40 | ||||||
7 | years with respect to 400
grams or more but less than | ||||||
8 | 900 grams of any substance containing heroin;
| ||||||
9 | (D) not less than 10 years and not more than 50 | ||||||
10 | years with respect to
900 grams or more of any | ||||||
11 | substance containing heroin;
| ||||||
12 | (2) (A) not less than 4 years and not more than 15 | ||||||
13 | years with respect
to 15 grams or more but less than | ||||||
14 | 100 grams of any substance containing
cocaine;
| ||||||
15 | (B) not less than 6 years and not more than 30 | ||||||
16 | years with respect to 100
grams or more but less than | ||||||
17 | 400 grams of any substance containing cocaine;
| ||||||
18 | (C) not less than 8 years and not more than 40 | ||||||
19 | years with respect to 400
grams or more but less than | ||||||
20 | 900 grams of any substance containing cocaine;
| ||||||
21 | (D) not less than 10 years and not more than 50 | ||||||
22 | years with respect to
900 grams or more of any | ||||||
23 | substance containing cocaine;
| ||||||
24 | (3) (A) not less than 4 years and not more than 15 | ||||||
25 | years with respect
to 15 grams or more but less than | ||||||
26 | 100 grams of any substance containing
morphine;
|
| |||||||
| |||||||
1 | (B) not less than 6 years and not more than 30 | ||||||
2 | years with respect to 100
grams or more but less than | ||||||
3 | 400 grams of any substance containing morphine;
| ||||||
4 | (C) not less than 6 years and not more than 40 | ||||||
5 | years with respect to 400
grams or more but less than | ||||||
6 | 900 grams of any substance containing morphine;
| ||||||
7 | (D) not less than 10 years and not more than 50 | ||||||
8 | years with respect to
900 grams or more of any | ||||||
9 | substance containing morphine;
| ||||||
10 | (4) 200 grams or more of any substance containing | ||||||
11 | peyote;
| ||||||
12 | (5) 200 grams or more of any substance containing a | ||||||
13 | derivative of
barbituric acid or any of the salts of a | ||||||
14 | derivative of barbituric acid;
| ||||||
15 | (6) 200 grams or more of any substance containing | ||||||
16 | amphetamine or any salt
of an optical isomer of | ||||||
17 | amphetamine;
| ||||||
18 | (6.5) (blank);
| ||||||
19 | (7) (A) not less than 4 years and not more than 15 | ||||||
20 | years with respect
to: (i) 15 grams or more but less | ||||||
21 | than 100 grams of any substance containing
lysergic | ||||||
22 | acid diethylamide (LSD), or an analog thereof, or (ii) | ||||||
23 | 15 or
more objects or 15 or more segregated parts of an | ||||||
24 | object or objects but
less than 200 objects or 200 | ||||||
25 | segregated parts of an object or objects
containing in | ||||||
26 | them or having upon them any amount of any substance
|
| |||||||
| |||||||
1 | containing lysergic acid diethylamide (LSD), or an | ||||||
2 | analog thereof;
| ||||||
3 | (B) not less than 6 years and not more than 30 | ||||||
4 | years with respect
to: (i) 100 grams or more but less | ||||||
5 | than 400 grams of any substance
containing lysergic | ||||||
6 | acid diethylamide (LSD), or an analog thereof, or (ii)
| ||||||
7 | 200 or more objects or 200 or more segregated parts of | ||||||
8 | an object or objects
but less than 600 objects or less | ||||||
9 | than 600 segregated parts of an object or
objects | ||||||
10 | containing in them or having upon them any amount of | ||||||
11 | any substance
containing lysergic acid diethylamide | ||||||
12 | (LSD), or an analog thereof;
| ||||||
13 | (C) not less than 8 years and not more than 40 | ||||||
14 | years with respect
to: (i) 400 grams or more but less | ||||||
15 | than 900 grams of any substance
containing lysergic | ||||||
16 | acid diethylamide (LSD), or an analog thereof, or (ii)
| ||||||
17 | 600 or more objects or 600 or more segregated parts of | ||||||
18 | an object or objects
but less than 1500 objects or 1500 | ||||||
19 | segregated parts of an object or objects
containing in | ||||||
20 | them or having upon them any amount of any substance
| ||||||
21 | containing lysergic acid diethylamide (LSD), or an | ||||||
22 | analog thereof;
| ||||||
23 | (D) not less than 10 years and not more than 50 | ||||||
24 | years with respect
to: (i) 900 grams or more of any | ||||||
25 | substance containing lysergic acid
diethylamide (LSD), | ||||||
26 | or an analog thereof, or (ii) 1500 or more objects or
|
| |||||||
| |||||||
1 | 1500 or more segregated parts of an object or objects | ||||||
2 | containing in them or
having upon them any amount of a | ||||||
3 | substance containing lysergic acid
diethylamide (LSD), | ||||||
4 | or an analog thereof;
| ||||||
5 | (7.5) (A) not less than 4 years and not more than 15 | ||||||
6 | years with respect
to: (i) 15
grams or more but
less | ||||||
7 | than 100 grams of any substance listed in paragraph | ||||||
8 | (1), (2), (2.1), (2.2), (3),
(14.1), (19),
(20), | ||||||
9 | (20.1), (21), (25), or (26) of subsection (d) of | ||||||
10 | Section 204, or an
analog or derivative
thereof, or | ||||||
11 | (ii) 15 or more pills, tablets, caplets, capsules, or | ||||||
12 | objects but
less than 200 pills,
tablets, caplets, | ||||||
13 | capsules, or objects containing in them or having upon | ||||||
14 | them
any amount of any
substance listed in paragraph | ||||||
15 | (1), (2), (2.1), (2.2), (3), (14.1), (19), (20), | ||||||
16 | (20.1),
(21), (25), or (26) of
subsection (d) of | ||||||
17 | Section 204, or an analog or derivative thereof;
| ||||||
18 | (B) not less than 6 years and not more than 30 | ||||||
19 | years with respect to: (i)
100
grams or more but
less | ||||||
20 | than 400 grams of any substance listed in paragraph | ||||||
21 | (1), (2), (2.1), (2.2), (3),
(14.1), (19), (20),
| ||||||
22 | (20.1), (21), (25), or (26) of subsection (d) of | ||||||
23 | Section 204, or an analog or
derivative thereof, or
| ||||||
24 | (ii) 200 or more pills, tablets, caplets, capsules, or | ||||||
25 | objects but less than
600
pills, tablets,
caplets, | ||||||
26 | capsules, or objects containing in them or having upon |
| |||||||
| |||||||
1 | them any amount
of any
substance
listed in paragraph | ||||||
2 | (1), (2), (2.1), (2.2), (3), (14.1), (19), (20), | ||||||
3 | (20.1), (21),
(25), or (26) of subsection
(d) of | ||||||
4 | Section 204, or an analog or derivative thereof;
| ||||||
5 | (C) not less than 8 years and not more than 40 | ||||||
6 | years with respect to: (i)
400
grams or more but
less | ||||||
7 | than 900 grams of any substance listed in paragraph | ||||||
8 | (1), (2), (2.1), (2.2), (3),
(14.1), (19), (20),
| ||||||
9 | (20.1), (21), (25), or (26) of subsection (d) of | ||||||
10 | Section 204, or an analog or
derivative thereof,
or | ||||||
11 | (ii) 600 or more pills, tablets, caplets, capsules, or | ||||||
12 | objects but less than
1,500 pills, tablets,
caplets, | ||||||
13 | capsules, or objects containing in them or having upon | ||||||
14 | them any amount
of any
substance listed in paragraph | ||||||
15 | (1), (2), (2.1), (2.2), (3), (14.1), (19), (20), | ||||||
16 | (20.1),
(21), (25), or (26) of
subsection (d) of | ||||||
17 | Section 204, or an analog or derivative thereof;
| ||||||
18 | (D) not less than 10 years and not more than 50 | ||||||
19 | years with respect to:
(i)
900 grams or more of
any | ||||||
20 | substance listed in paragraph (1), (2), (2.1), (2.2), | ||||||
21 | (3), (14.1), (19), (20),
(20.1), (21), (25), or (26)
of | ||||||
22 | subsection (d) of Section 204, or an analog or | ||||||
23 | derivative thereof, or (ii)
1,500 or more pills,
| ||||||
24 | tablets, caplets, capsules, or objects containing in | ||||||
25 | them or having upon them
any amount of a
substance | ||||||
26 | listed in paragraph (1), (2), (2.1), (2.2), (3), |
| |||||||
| |||||||
1 | (14.1), (19), (20), (20.1),
(21), (25), or (26) of
| ||||||
2 | subsection (d) of Section 204, or an analog or | ||||||
3 | derivative thereof;
| ||||||
4 | (8) 30 grams or more of any substance containing | ||||||
5 | pentazocine or any of
the salts, isomers and salts of | ||||||
6 | isomers of pentazocine, or an analog thereof;
| ||||||
7 | (9) 30 grams or more of any substance containing | ||||||
8 | methaqualone or any
of the salts, isomers and salts of | ||||||
9 | isomers of methaqualone;
| ||||||
10 | (10) 30 grams or more of any substance containing | ||||||
11 | phencyclidine or any
of the salts, isomers and salts of | ||||||
12 | isomers of phencyclidine (PCP);
| ||||||
13 | (10.5) 30 grams or more of any substance containing | ||||||
14 | ketamine or any of
the salts, isomers and salts of isomers | ||||||
15 | of ketamine;
| ||||||
16 | (11) 200 grams or more of any substance containing any | ||||||
17 | substance
classified as a narcotic drug in Schedules I or | ||||||
18 | II, or an analog thereof, which is not otherwise
included | ||||||
19 | in this subsection.
| ||||||
20 | (b) Any person sentenced with respect to violations of | ||||||
21 | paragraph (1),
(2), (3), (7), or (7.5) of subsection (a) | ||||||
22 | involving 100
grams or more of the
controlled substance named | ||||||
23 | therein, may in addition to the penalties
provided therein, be | ||||||
24 | fined an amount not to exceed $200,000 or the full
street value | ||||||
25 | of the controlled or counterfeit substances, whichever is
| ||||||
26 | greater. The term "street value" shall have the meaning
|
| |||||||
| |||||||
1 | ascribed in Section 110-5 of the Code of Criminal Procedure of | ||||||
2 | 1963. Any
person sentenced with respect to any other provision | ||||||
3 | of subsection (a), may
in addition to the penalties provided | ||||||
4 | therein, be fined an amount not to
exceed $200,000.
| ||||||
5 | (c) Any person who violates this Section with regard to an | ||||||
6 | amount
of a controlled substance other than methamphetamine or | ||||||
7 | counterfeit substance not set forth in
subsection (a) or (d) is | ||||||
8 | guilty of a Class 4 felony. The fine for a
violation punishable | ||||||
9 | under this subsection (c) shall not be more
than $25,000.
| ||||||
10 | (d) Any person who violates this Section with regard to any | ||||||
11 | amount of
anabolic steroid is guilty of a Class C misdemeanor
| ||||||
12 | for the first offense and a Class B misdemeanor for a | ||||||
13 | subsequent offense
committed within 2 years of a prior | ||||||
14 | conviction.
| ||||||
15 | (Source: P.A. 94-324, eff. 7-26-05; 94-556, eff. 9-11-05; | ||||||
16 | 95-331, eff. 8-21-07.)
|